Royal Bank Of Canada P Lx Pharma Inc. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.9 - $4.18 $54,068 - $118,950	-28,457 Reduced 99.15%	245 $1,000
Q1 2022 May 16, 2022	BUY	$3.54 - $8.3 $19,806 - $46,438	5,595 Added 24.21%	28,702 $116,000
Q4 2021 Feb 14, 2022	BUY	$7.69 - $19.66 $69,594 - $177,923	9,050 Added 64.38%	23,107 $185,000
Q3 2021 Nov 15, 2021	BUY	$12.22 - $21.28 $70,289 - $122,402	5,752 Added 69.26%	14,057 $271,000
Q2 2021 Aug 16, 2021	BUY	$9.0 - $15.94 $74,745 - $132,381	8,305 New	8,305 $115,000

61.6K

Ticker PLXP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 29,137,700
Description
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. The company's lead product candidates are Vazalore 325 mg for the patients with vascular events, such as heart attacks and clot-related strokes, as well as for use in conditions associated with pain and inflammation, including other asp...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.